Contribution of MicroRNAs in Chemoresistance to Cisplatin in the Top Five Deadliest Cancer: An Updated Review
Cisplatin (DDP) is a well-known anticancer drug used for the treatment of numerous human cancers in solid organs, including bladder, breast, cervical, head and neck squamous cell, ovarian, among others. Its most important mode of action is the DNA-platinum adducts formation, inducing DNA damage resp...
Saved in:
Main Authors: | Pía Loren (Author), Nicolás Saavedra (Author), Kathleen Saavedra (Author), Nadine De Godoy Torso (Author), Marília Berlofa Visacri (Author), Patricia Moriel (Author), Luis A. Salazar (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Epigenetic Mechanisms Involved in Cisplatin-Induced Nephrotoxicity: An Update
by: Pía Loren, et al.
Published: (2021) -
A comprehensive survey into the role of microRNAs in ovarian cancer chemoresistance; an updated overview
by: Ahmad Saburi, et al.
Published: (2022) -
MicroRNAs as the critical regulators of Cisplatin resistance in ovarian cancer cells
by: Meysam Moghbeli
Published: (2021) -
miR-6805-5p as a biomarker of cisplatin-induced nephrotoxicity in patients with head and neck cancer
by: Nadine De Godoy Torso, et al.
Published: (2023) -
MicroRNAs and Exercise / MicroRNAs unter Einfluss körperlicher Belastung
by: Meurer S, et al.
Published: (2016)